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Abstract
There is a growing appreciation by the biomedical community that studying the impact of sex and gender on
health, aging, and disease will lead to improvements in human health. Sex- and gender-based comparisons can
inform research on disease mechanisms and the development of new therapeutics as well as enhance scientific
rigor and reproducibility. This review will assist basic researchers, clinical investigators, as well as epidemiologists,
population, and social scientists by providing an annotated bibliography of currently available resource tools on
how to consider sex and gender as independent variables in research design and methodology. These resources
will assist investigators applying for funding from the National Institutes of Health since all grant applicants will be
required (as of January 25, 2016) to address the role of sex as a biological variable in vertebrate animal and human
studies.
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Background
While sex and gender differences in the etiology, age of
disease onset, symptomology, diagnostics, response to
treatment, and outcomes have long been known to exist
for key health outcomes in medicine, insufficient bio-
medical research and reporting on the impact of sex and
gender in health and disease still exists. For instance, sex
and gender differences exist in the pharmacokinetics
and pharmacodynamics of drug action [1]; however,
most basic science research is conducted based on a
male model. A survey of ten different disciplines includ-
ing neuroscience, physiology, pharmacology, endocrin-
ology, zoology, and behavioral science demonstrated that
the majority of studies published in 2009 were con-
ducted in male animals [2]. Furthermore, the Food and
Drug Administration (FDA) does not require phase II
clinical studies to compare dose and efficacy between
men and women. Women made up less than 33 % of the
participants in phase I trials approved by the FDA be-
tween 2006 and 2007 [3], and women have been under-
represented in phase III clinical trials of certain drug
classes, including those that target renal and cardiovas-
cular disease [4]. Moreover, there are no mandatory
FDA requirements for prospectively designing clinical
trials to investigate the impact of one’s sex on drug re-
ceptivity or adverse effects or for conducting appropriate
and complete analyses by sex.
To address the underrepresentation of females in
biomedical research, the National Institutes of Health
(NIH) released a notice on June 9, 2015 entitled, Consid-
eration of Sex as a Biological Variable in NIH-funded
Biomedical Research that focuses on the “expectation
that scientists will account for the possible role of sex as
a biological variable in vertebrate animal and human
studies” [5]. Furthermore, updated application instructions
and review questions take effect for NIH applications sub-
mitted for the January 25, 2016 due date and thereafter.
Greater understanding of the sex differences in incidence
and progression of diseases will come from intensified
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study of the “sexome,” the sum of sex-biased effects on
gene networks, and diverse cell and tissue systems [6].
To assist investigators in incorporating sex and gender
into their research design and methodology, this review
provides an annotated bibliography of currently available
resources for conducting sex and gender research and
analysis. The authors defined a resource as a broadly
based tool that can be used to guide both novice and ex-
perienced researchers to consider the impact of sex and
gender differences within research design and method-
ology. The authors believe that variables such as sex and
gender are not monolithic variables but rather variables
that interact and frequently reinforce each other. Exam-
ples of other variables that interact with biological sex
include age, race, ethnicity, class, sexual orientation, and
sexual identity. This review focuses on sex and gender as
independent variables, as the first step in identifying
their impact in medical research and health outcomes.
Methods
The research team included seven academic researchers,
both basic science and clinical science, from US univer-
sities. Together, they developed a protocol to guide the
review process of material to be included in this re-
source. The review protocol included defining research
questions, establishing the need for the review, inclusion
and exclusion criteria, review period, timeline, and the
resource selection/evaluation process.
The review was conducted to answer the following
research questions:
1. What specific resources are available to assist
students, researchers, educators, and policy makers
with incorporation of sex and gender into health
research design?
2. What is the format of the publication describing
each resource? (journal article, review paper, report,
webinar, book, case study, recorded didactic
presentations)
3. To what extent are these resources freely available?
4. Who is the intended audience for these resources?
5. What is the major utility of each resource?
6. What is the level of “ease of use” for each resource?
7. What is the level of evidence on which the resources
are based?
As a first step, we identified the need for a review of
resources; an initial search of the literature did not re-
veal a review of resources on the topic. In 2014, the au-
thors systematically searched published literature online
(Medline using PubMed, Web of Science, Embase and
Google Scholar for articles, text books, and other types of
published resources) and by hand-search (bibliographies).
The following search terms were used: sex analysis AND
gender analysis AND tools for gender analysis AND re-
search methods for sex and gender AND designing sex
and gender analysis AND designing sex and gender re-
search AND gender-based analysis. The period of review
included articles published up to 2014 with no beginning
date.
Data collection and analysis
A “resources selection checklist” was developed to deter-
mine the eligibility of resources for inclusion in the re-
view. Both basic and clinical science resources were
included. Inclusion criteria required publication in the
English language. The initial search yielded 69 resources.
Each resource was examined to see if any additional cita-
tions could be located. From these searches, after elimin-
ating resources that did not meet eligibility criteria, 38
resources were identified and a database of these re-
sources was created.
There were a total of seven reviewers. The authors were
divided into review teams, and each team had either two
or three members. Each member of a review team inde-
pendently assessed the identified resource and later com-
pared and discussed their assessments with other team
members to reach consensus. Disagreements were re-
solved through discussion or, if required, via adjudication
by a third reviewer. Articles were excluded if, after review,
they were not considered resources. A form was devel-
oped to extract data. Articles that were considered appro-
priate for inclusion after review team discussion were
entered into a table using the data extraction form and
reviewed in depth to answer the study research questions.
Table 1 presents the criteria used for data extraction.
It should be noted that two of the criteria were later
removed from final results “Audience” and “Level of
Evidence”. The authors realized that the Audience could
be broadly interpreted and many of the categories over-
lapped. The authors also discovered that there was insuf-




After reviewing the final 38 resources, the research
team divided them into five subcategories based upon
similarities in research topic area. These were Basic
Science; Clinical Research; Pharmaceuticals, Biologics,
Pharmacokinetics, Devices; Epidemiology and Public
Health; and Social and Cultural. The subcategories and
the corresponding resources are presented in Table 2 and
summarized below:
Basic Science
In a systematic review entitled “Sex Bias in Neuroscience
and Biomedical Research,” the authors found that for
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every single-sex study conducted in nonhuman female an-
imals in 2009, there were significantly more conducted in
males across eight out of ten biological disciplines. Re-
markably, in the field of neuroscience the male-to-female
ratio of single-sex studies was 5.5:1 [2]. The authors exam-
ined how the investigator preference for studying male
animals originated, and they discuss the adverse conse-
quences of this male sex bias in preclinical research for
human health. This article is an excellent resource for
gaining an understanding of the historic existence of a sex
bias in preclinical animal and human research across ten
major biological disciplines including Animal Behavior,
Behavioral Physiology, Endocrinology, General Biology,
Immunology, Neuroscience, Pharmacology, Physiology,
Reproduction, and Zoology. One of the reasons preclinical
research has historically been predominantly conducted
on male animals is the mistaken assumption that female
mammals are intrinsically more variable than males be-
cause of the estrous cycle. This assumption of greater fe-
male trait variability was called into question by Mogil
and Chanda, who conducted a meta-analysis of nocicep-
tive responses in forty strains of inbred mice and con-
cluded that there were no sex differences in the response
variability [7]. The article “Female mice liberated for
inclusion in neuroscience and biomedical research” by
Prendergast et al. is an excellent resource that ex-
tends these findings of Mogil and Chanda through a
systematic review of the literature on the variability
in behavioral, morphological, physiological, and mo-
lecular traits between male and female mice without
consideration of the estrous cycle stage [8]. The au-
thors found that for any endpoint studied, variability
was not greater in females than males and in fact for
several traits, the variability was greater in males.
“Sex differences in the Brain: The Not So Inconvenient
Truth” is an excellent resource for understanding how
to operationally categorize sex differences in endpoints
[9]. The authors identify three classes of sex differences.
Type I, classified “sexual dimorphism” is defined as an
endpoint consisting of two forms. Included in type I dif-
ferences are endpoints that are present in one sex but
not the other. For example, only females get pregnant or,
for behaviors, courtship rituals, and copulatory behavior
differs between males and females. Type II, “sex differ-
ences” are defined as endpoints that exists on a con-
tinuum with the average or the variability around that
average differing between the sexes as in pain sensitivity
or olfactory recall ability. Type III, “sex convergence and
divergence” defines endpoints that are the same in males
and females but in which route to achieve the endpoint
differs as in problem solving strategies in spatial learning
tasks or endpoints that are identical at baseline but di-
verge in response to a particular challenge such as sex
differences in vulnerability to environmental toxins. This
paper is also a resource for how to study the cause of
sex differences and includes decision tree strategies and
the methodology for addressing these strategies. For ex-
ample, the first recommended experiment is to deter-
mine if a sex difference is due to gonadal hormones
since most reported sex differences are due to adult go-
nadal hormone levels. To address this question, the out-
come parameter is compared between adult males and
females in the intact and gonadectomized state. Then,
depending upon the findings, gonadal hormone re-
placement studies may be indicated. While this article
focuses on the brain, the concepts are relevant to
many disciplines.
Another valuable resource for investigators interested
in studying the causes of sex differences, not only in the
brain but in also other fields as well, is “Strategies and
Methods for Research on Sex Differences in Brain and
Behavior” [10]. The authors organized this paper as a
series of decision tree questions and then provided
highly detailed methodologies on how to study the role
of male and female gonadal hormones using endocrine
ablation and hormone replacement therapy in animals
and how to differentiate developmental from adult origin
gonadal hormone effects. In addition, the authors dis-
cuss animal models that can be used to investigate the
role of the sex chromosomes independently of the go-
nadal hormones and vice versa. Becker et al. offer de-
tailed methods and caveats for measuring sex hormones
in serum and saliva and the importance of taking into
account the impact of stress in the study of sex
Table 1 Data extraction criteria
Format o Journal article about one resource












o Book most libraries would have
o Book available in a university library
o Book for purchase








Level of evidence Initial criterion: abandoned due to lack of evidence
or not noted
The Author(s) Biology of Sex Differences 2016, 7(Suppl 1):46 Page 63 of 103
Table 2 Resources on conducting sex and gender Research
Subcategory Resource title Author Resource type Availability
1. Basic Science Strategies and Methods for Research
on Sex Differences in Brain and
Behavior
Becker, J.B., et al. Journal article b, c
Sex Differences in the Brain: The Not
So Inconvenient Truth
McCarthy, M.M., et al. Journal article a, f
Strategies and methods to study sex
differences in cardiovascular structure
and function: a guide for basic
scientists
Miller, V.M., Kaplan, J.R.,
Schork, N.J. et al.
Journal article a, c
Integrating the dimensions of sex
and gender into basic life sciences
research: methodologic and ethical
issues
Holdcroft, A Journal article c
Sex bias in neuroscience and
biomedical research
Beery, A.K. and Zucker, I. Journal article b, c
2. Clinical Research Sex and Gender Subgroup Analyses
of Randomized Trials: The Need to
Proceed With Caution
Aulakh, A.K., et al. Journal article b, c
Studying sex and gender differences
in pain and analgesia: a consensus
report
Greenspan, J.D., et al. Journal article b, c
Sex and Gender in Systematic
Reviews Planning Tool
Doull M., Runnels V.,







Better Science with Sex and Gender:
A Primer for Health Research








Thinking Critically About Research on
Sex and Gender
PJ Caplan and JB Caplan Book f, g, h
Designing and Conducting Gender,
Sex & Health Research
Lindsay and Greaves Book b, e, f, g
Appraising the evidence: applying
sex- and gender-based analysis
(SGBA) to Cochrane Systematic
Reviews on cardiovascular diseases.
Doull, M et al. Journal article a, c
Scientific excellence in applying sex-
and gender-sensitive methods in




Gender Awakening Tool. Bibliography:
Sex & Gender in Biomedical and
Health Research
Gender Basic Online tool
(www.genderbasic.nl)
c
The Hidden Science in Your
Emergency Medicine Research:







Sex and Gender Differences in
Alzheimer’s Disease: Recommendations
for Future Research
Carter, C.L., Resnick, E.M.,
Mallampalli, M.,
Kalbarczyk, A.
Journal article b, c
An interdisciplinary analysis of sex
and gender in relation to the
pathogenesis of bronchial asthma
Lux, R., Awa, W.,
Walter, U.
Journal article b, c
Sex Differences and Implications for
Translational Neuroscience Research:
Workshop Summary
IOM Journal article c, d, h
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Table 2 Resources on conducting sex and gender Research (Continued)
3. Pharmaceuticals, Biologics,
Pharmacokinetics, Devices
Participation of Women and Sex
Analyses in Late-Phase Clinical Trials
of New Molecular Entity Drugs and
Biologics Approved by the FDA in
2007-2009
Poon, R., Khanijow, K.
et al.
Journal article b
Sex, Gender, and Pharmaceutical
Politics: From Drug Development to
Marketing









How important are gender differences
in pharmacokinetics?
Meibohm, B., Beierle, I.,
Derendorf, H.
Journal article b
Methodologic ramifications of paying
attention to sex and gender
differences in clinical research
M. Prins, et al. Journal article b
4. Epidemiology and
Public Health
Sex and gender: the challenges for
epidemiologists
Doyal, L. Journal article b
Methodologic and Ethical Ramifications




Journal article b, c
(not free)
Rising to the Challenge: Sex and
gender-based analysis for health
planning, policy and research in
Canada






Women and Occupational Lung
Disease: Sex Differences and Gender
Influences on Research and Disease
Outcomes
Camp, P.G., Dimich-Ward, H.,
Kennedy, S.M.
Journal article b, c
Genders, Sexes and Health: What are
the Connections-and Why Does it
Matter?
Krieger, N. Journal article b, c
Neurotoxic exposures and effects:
Gender and sex matter!
Mergler, D. Journal article b, c
5. Social and Cultural Intersectionality: Moving Women’s
Health Research and Policy Forward






A Toolkit on Collecting Gender &








A Tool for Developing Gender
Research in Medicine: Examples from
the Medical Literature on Work Life
Hammarström, A Journal article b, c
Central Gender Theoretical Concepts
in Health Research: The State of the Art
Hammarström, A.,
Johansson K., Annandale, E.,
Ahlgren, C., et al.
Journal article b
Doing gender in sex and sex research Vanwesenbeeck, I Journal article a, b, c
a Free online journal (free)
b University library (UL)
c Internet access (free)
d Free e-book (free)
e Purchase e-book (purchase)
f Book most libraries would have (purchase)
g Book available in a university library (UL)
h Book for purchase (purchase)
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differences of a particular trait. This paper also dis-
cusses how to gain insight into the cause of sex dif-
ferences in humans by taking advantage of naturally
occurring changes in the endocrine state across the
male and female life span. Missing from this review,
however, is the value of using naturally occurring
endocrine disorders (e.g., polycystic ovary disease) and
sex chromosome abnormalities (e.g., Turner Syndrome
and Klinefelter syndrome) and studies of surgical or
chemical clinical interventions (e.g., elective oophorec-
tomies and super agonist-induced ablation of testos-
terone production).
Another excellent resource for investigators inter-
ested in how to design and conduct investigations
into the cause of sex differences using cells and tis-
sues from animals or whole animal physiology was
written by Miller et.al. In addition to design consider-
ations and choice of experimental models, in “Strategies
and methods to study sex differences in cardiovascular
structure and function: a guide for basic scientists”,
the authors discuss the impact of the sex, environ-
ment, and history of the animal harvested for studies
using animal tissues and cells with an emphasis on
cardiovascular research; however, the approaches dis-
cussed are relevant for other fields as well [11]. This
article highlights the need to consider reproductive
status (e.g., pre- or post-pubertal, virgin, or numerous
pregnancies) as well as the environment in which the
animal lived including whether or not the animal was
exposed to diets rich in phytoestrogens, experienced
disrupted sleep/wake cycles, and/or subjected to social
isolation or interaction. In addition, Miller et al.
emphasize the importance of considering sex as a di-
chotomous variable as well as a covariate when both
sexes are included within a study.
The use of the term “gender” in animal research re-
mains controversial with some investigators preferring
the word “sex” when referring to all studies of non-
human male and female animals, while the Institute of
Medicine [12] uses “gender” to define “the biology that
is shaped by environment and experience”. Using the
Institute of Medicine definition of “gender” in “Integrating
the Dimensions of Sex and Gender into Basic Life
Sciences Research: Methodologic and Ethical Issues” dis-
cusses the need to consider the impact of animal-to-
animal interaction, i.e., the role of the physical and social
environment in which animals are housed, as well as the
role of the impact of the sex of the animal handler on the
animal due to sex differences in human odors, sounds,
and animal handling [13].
This paper is also an excellent reference for under-
standing the impact of how the accumulation of small
sex differences can have major effects on outcomes.
Methodological approaches to being able to recognize
small sex differences by reducing experimental vari-
ation, sufficiently powering studies, and by conducting
meta-analyses are presented. In addition, this article
provides a valuable resource for considering over-
looked variables in designing sex difference research
including sex differences in the pharmacokinetics and
pharmacodynamics of drug action when conducting a
pharmacological intervention. This is an excellent re-
source for Animal Care and Use Committees during
their review of animal protocols as Holdcroft recom-
mends guidelines for encouraging disclosure of infor-
mation that affects sex or gender differences such as
strain variations and age of animals. Moreover, she
provides the rationale for why preclinical research de-
sign should consider the impact of sex on disease in-
cidence and outcomes.
Clinical Research
“Sex and Gender Subgroup Analyses of Randomized
Trials” extends a vital message for researchers interested
in conducting sex and gender subgroup analyses (SGA)
of randomized clinical trials [14]. Investigators are cau-
tioned that the possibility exists for misleading results
for improperly conducted SGA, which could mistakenly
influence medical management. Through a search of
cardiovascular randomized clinical trials, the authors
make the case that only 1/3 of them provided evidence
of conducting a proper SGA. Guidelines for performing
and interpreting a rigorous SGA are summarized in
Table 3.
For a comprehensive primer to serve as a guide in
conducting sex and gender-based analysis (SGBA)
across the continuum of biomedical research, “Better
Science with Sex and Gender: A Primer for Health
Research” does just that [15]. This small book is ac-
cessible to those with even basic understanding of
biology and outlines designs for SGBA within basic
science and preclinical studies, clinical and healthcare
systems research, and social and cultural determi-
nants. Missing within its context are references con-
cerning biomedical device, biomarker, and diagnostic
test developments, which are important components
of SGBA approaches.
Table 3 Guidelines for conducting rigorous subgroup analysis
by sex and gender in randomized controlled trials
1 State the subgroup analysis a priori
2 Provide a rationale for performing the subgroup analysis
3 Offer a hypothesis regarding the outcome of the subgroup analysis
4 Adjust p values for the number of comparisons being made
5 Emphasize overall findings instead of subgroup analysis findings
because results can only be considered hypothesis generating
Adapted from “Sex and Gender Subgroup Analyses of Randomized Trials”
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The following resources for incorporating sex and gen-
der into clinical research design and analysis referred to
in publications as “Tools”:
To plan health interventions or outcomes with the
intent of performing a SGA, the appraisal tool, “Sex
and Gender in Systematic Reviews Planning Tool”,
assists researchers with the inclusion of appropriate
questions regarding the possible impact of sex and
gender [16]. The tool itself is easy to use and consists
of six series of questions that include Background,
Criteria for considering studies, Methods, Results and
Analysis, Discussion and Conclusion, and Table of
Included Studies.
“Scientific Excellence in Applying Sex- and Gender-
Sensitive Methods in Biomedical and Health Research”
is the result of a workshop, “Scientific Excellence and
‘Sexy’ Research”, organized by the authors to develop
methods of conducting sex and gender sensitive
research and develop a tool that allows for detection
of sex and gender bias throughout all phases of the
research process [17]. The tool is a seven-step plan
that reviews the main sex and gender issues to consider
in each stage of research including (1) Relevance Check,
(2) Literature Search, (3) Formulation of research
questions and hypotheses, (4) Research methods and
sample, (5) Data analysis and interpretation, (6)
Reporting, and (7) Conclusions and recommendations.
This resource is valuable for a broad range of scientists
and offers an easy to use checklist designed to assist the
integration of sex and gender aspects in biomedical ad
health research methodologies.
The “Gender Awakening Tool” is an online tool
developed by the Center for Gender and Diversity at
the Maastricht University in The Netherlands and
adopted by the European Commission, with the aim of
ensuring better integration of gender dimensions in
basic life sciences research [18]. It provides an earlier
version of the seven questions described above;
however, it has limited utility as an actual tool and
serves more in the capacity to promote and create
awareness for consideration of sex and gender in
research design.
The Sex and Gender Appraisal Tool for Systematic
Reviews (SGAT-SR) is described in “Appraising the
Evidence: Applying Sex- and Gender-Based Analysis
(SGBA) to Cochrane Systemic Reviews on Cardiovascular
Diseases” [19]. The SGAT-SR was developed by the
authors and is composed of 35 items which appraise
the nine sections of a Cochrane review: (1) Background,
(2) Objectives, (3) Criteria for inclusion/exclusion, (4)
Search strategy, (5) Methods, (6) Analysis, (7) Discussion
and Conclusions, (8) Quality assessment, and (9) Table of
included studies [19]. This tool has not been externally
validated but is systematic, detailed, and should be useful
to assess appropriate application of SGBA to the
evidence synthesized by systematic reviews across
disciplines.
Several articles address the evidence of sex differences
in specific disciplines and disease processes “An
Interdisciplinary Analysis of Sex and Gender in
Relation to the Pathogenesis of Bronchial Asthma,”
“Sex and Gender Differences in Alzheimer’s Disease:
Recommendations for Future Research,” and “Studying
Sex and Gender Differences in Pain and Analgesia: A
Consensus Report” [20]. These are invaluable resources
to assist researchers in identifying sex-based research
questions for future areas of study in particular medical
specialties. “Sex Differences and Implications for
Translational Neuroscience Research: Workshop
Summary” is an extensive report approved by the
Governing Board of the U.S. National Research
Council (2011) with recommendations for studying
sex differences in medicine, translational research,
drug development, and reporting these differences in
research publications [21]. This broader viewpoint
enables this resource to be a valuable template for
workshops addressing sex differences in many
disciplines.
For those inclined to watch video presentations,
The Society for Academic Emergency Medicine
hosted a didactic presentation moderated by Choo,
EK, called “The Hidden Science in Your Emergency
Medicine Research: Gender-Specific Study Design
and Analysis” [22]. This symposium covers examples
of sex differences in outcome and diagnostics using
traumatic brain injury and cardiovascular research as
examples, which serves as a useful motivator for
researchers to explore sex differences in clinical
medicine. There is also a focus on statistical design
of studies assessing the impact of sex and gender.
Additionally, two books were identified as clinical
research resources. The first, “Thinking Critically
About Research on Sex and Gender” provides one of
the earliest sources of guidance in conducting sex and
gender research as it was copyrighted in 1994 [23].
Included in the book is a history of the science of sex
differences, a description of the scientific method, and
particular chapters on what were current issues at the
time, including math, spatial ability, women and
masochism, males and aggression, mother-blame,
women and hormones, verbal ability, and dependence
of females. Its limitations lie in the fact that it is over
20 years old and the information is mainly historical.
However, surprisingly, it is still relevant. “Designing and
Conducting Gender, Sex, & Health Research” thoroughly
examines study concepts, design, measurement,
qualitative analysis, and public health policies divided
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into three parts as areas of considerations for gender
and sex research [24]. A collective of chapter authors
from the Canadian Fulbright Regional Network for
Applied Research (NEXUS) Program contributed to this
comprehensive resource.
Pharmaceuticals, Biologics, Pharmacokinetics, and Devices
“Sex, Gender, and Pharmaceutical Politics: From Drug
Development to Marketing” provides an overview of the
drug development process [25]. This resource is helpful
to researchers to understand US and international drug
regulation and marketing as well as clinical drug devel-
opment. Cases of both underinclusion and overinclusion
of women in clinical drug development programs are
presented and associated efficacy and safety concerns are
discussed. “Participation of Women and Sex Analyses in
Late-Phase Clinical Trial” presents a method to assess par-
ticipation by women in late phase clinical trials of drugs
and biologics [26]. Ratios were calculated according to the
proportion of women in the disease population. Presenta-
tion of the ratio for new drugs by disease and for biologics
by disease is presented for multiple diseases. This analysis
can assess the adequacy of representation by female sub-
jects in clinical trials.
While the goal was to report on sex and gender
differences in pharmacogenetic studies, “Methodologic
Ramifications of Paying Attention to Sex and Gender
Differences in Clinical Research” is a resource for report-
ing sex and gender in clinical research in general [27].
Included is a table with a helpful list of questions to ask
about study design and analysis when thinking about sex
and gender issues in clinical research. “How Important
are Gender Differences in Pharmacokinetics?” reviews
mechanisms relevant to drug absorption and distribution
that have been shown to exert gender-specific activity
differences [28]. This well-organized article could pro-
vide a path to investigate gender differences in pharma-
cokinetics for a new drug, but it should be noted that
pregnant women and women on hormonal therapies
were excluded from this review.
In “DeGendering the Knee: Overemphasizing Sex
Differences as a Problem,” a medical marketing case
study is presented [29]. This case puts forward the idea
that sex differences can be overemphasized to the exclu-
sion of other factors, such as height and weight. Thus,
sex differences can be emphasized for reasons having
more to do with medical marketing than optimal patient
care.
Epidemiology and Public Health
“Sex and Gender: The Challenges for Epidemiologists” is
an excellent piece that acknowledges limitations in epi-
demiologic and statistical analysis in performing and
declaring research designed to depict sex and gender
differences [30]. It begins by defining sex and gender
and underscores the importance of sex and gender re-
search. The authors further outline challenges in deter-
mining accurate differences attributable to sex and
gender, from an epidemiologists’ perspective, and re-
views strategies for mainstreaming sex and gender into
health research.
“Methodologic and Ethical Ramifications of Sex and
Gender Differences in Public Health Research” is a re-
view of articles that examine the current status of gender
in public health research [31]. The review thoroughly
discusses ethical barriers to public health studies. It an-
swers as well as discusses questions on gender biases,
ethics, and methodologies, and the establishment of
guidelines and offers recommendations for improving
gender representation and evaluation on ethics com-
mittees and in public health research methodology
(including that data are disaggregated by sex and by
socioeconomic factors).
“Rising to the Challenge: Sex and gender-based ana-
lysis for health planning, policy and research in Canada”
is an in-depth source of information about sex/gender
and processes that recognize the effects of sex and gen-
der in research, policy, programs, etc. [32]. This resource
provides background on the origins of sex- and gender-
based analysis and the major concepts of sex, gender, di-
versity, and equity as well as how these concepts relate
to health. It also provides guidance on how to conduct
sex- and gender-based analysis. This piece stresses the
importance of assessing the impact of other variables
(e.g., age, ethnicity, race, and socio economic status) on
health, and provides case studies illustrating the power
of sex and gender bases analyses for understanding dif-
ferent types of health, health care, and health policy is-
sues. It complements introductory guides and checklists
by inviting readers to engage in a deeper, extended
discussion about the changing meanings of “sex” and
“gender” and their current and potential roles in health
and society. It introduces the concept that more com-
plex analyses are key to moving beyond simple assess-
ments of differences between women and men toward
an understanding of why these differences exist and how
best to respond to them. Finally, this resource treats sex-
and gender-based analysis as a process, rather than a
tool or template, thereby emphasizing its flexibility and
transferability across sectors, disciplines, and regions.
“Women and Occupational Lung Disease: Sex
Differences and Gender Influences on Research and
Disease Outcomes” is a journal article review that is
readily accessible to those with a general understand-
ing of human subject research [33]. This article de-
scribes the limitations of what is known regarding the
role of gender in occupational lung disease. The authors
focus attention on the challenges faced by researchers
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when investigating the impact of gender in occupational
health and disease, which includes sex and gender differ-
ences in tasks, work shifts, effectiveness of protective
practices and measures, lung mechanics, co-morbidities,
and pre-existing conditions as well as the limitations in
record keeping by sex. The authors do not separate the
concepts of sex and gender in their review; identified gaps
in knowledge include the lack of specific data being col-
lected by sex and/or gender such as symptom reporting
and the potential role of gender bias in reporting. This
resource serves as an example of the methodological chal-
lenges that face researchers when investigating the influ-
ence of sex and gender in occupational-associated diseases
including differences in perception, and the interaction of
environmental, sociocultural, and biologic factors.
“Genders, Sexes and Health: What are the Connections-
and Why Does it Matter?” is a commentary and analysis
that summarizes the conceptual debates leading to dis-
tinctions between “sex” and “gender” as biological and so-
cial constructs [34]. The resource can be used as a guide
in integrating gender mainstreaming at every stage of re-
search. This article educates scientific researchers in the
complexity and multiple ways the factors of sex and gen-
der can independently and synergistically affect health
outcomes. The case examples presented in the paper high-
light that gender relations influence expression—and
interpretation—of biological traits, and also that sex-
linked biological characteristics can, in some cases, con-
tribute to or amplify gender differentials in health.
“Neurotoxic exposures and effects: Gender and sex
matter!” is a well-organized review article and tool that
summarizes evidence on sex and gender differences in
neurotoxic exposure and provide suggestions for sex-
and gender-sensitive research in neurotoxicology [35].
The author breaks down suggestions to apply to each
step of the research process, from developing research
questions and study design to conducting the study,
analyzing and interpreting findings, to publication of
findings.
This resource will be most useful to researchers, scien-
tific journal editors, and grant funders.
Social and Cultural
“Central Gender Theoretical Concepts in Health Research:
The State of the Art” clarifies key concepts and language
used in sex and gender research critical to research design
and manuscript development [36]. It highlights the im-
portance of classifying gender theoretical concepts as cen-
tral and interlinked in health sciences through definitions
of sex, gender, intersectionality, embodiment, gender
equity, and gender equality. “Doing gender in sex and sex
research. Archives of Sexual Behavior” is a discussion of
gender versus sex with gendered sexuality as a social
process [37]. This particular essay discusses ten difficulties
in the treatment of gender in sex research, reflects on their
origins, and reviews the theory behind it. This resource
may be useful to researchers as a basic platform for
gender-based studies.
“Moving Women’s Health Research and Policy Forward”
addresses the critical concept of “Intersectionality” [38].
Women’s health and experiences are shaped not only by
sex and gender but also by other factors such as race,
class, culture, income, education, age, ability, sexual orien-
tation, immigration status, ethnicity, indigeneity, geog-
raphy, and so on. The purpose of this primer is to explore
the following question: How can health researchers, policy
analysts, program and/service managers, decision makers,
and academics effectively apply an intersectional perspec-
tive to their day-to-day work? The primer includes the
following: an overview of intersectionality including
challenges and advantages of this approach; a discussion
of the key assumptions of intersectionality; comparison
and contrast of an intersectional approach, a gender- or
sex-based approach, a health determinants approach,
community-based research, and indigenous approaches; a
discussion of the need for an intersectional approach in
gender and women’s health research; discussion of how to
integrate an intersectional approach into health research;
a discussion of how to integrate an intersectional ap-
proach into health policymaking; and examples of the ap-
plication of an intersectional framework to three health
issues.
“A Toolkit on Collecting Gender & Assets Data in
Qualitative & Quantitative Program Evaluations” is a
toolkit devised to assist data collection on household as-
sets for research on development programs [39]. Previ-
ous research in this area used pooled data from both
genders; where in actuality men and women have and
use their household assets differently. This toolkit pro-
vides definitions, statistical methods, and case studies
designed to assist the researcher in collecting appropri-
ate gender data. This online toolkit is organized in three
sections. The first section provides an overview of the
key concepts in gender and asset ownership. The second
section describes measures for assessing the impact of
gender on asset data collection including the tools, best
practices, and approaches as well as the limitations of
these methods. The final section summarizes the best
practices and provides key recommendations for gender
asset collection. An appendix offers additional resources,
case studies, and a guide for integrating gender into
household surveys.
“A Tool for Developing Gender Research in Medicine:
Examples from the Medical Literature on Work Life”
[40] is a journal article that has two objectives. One is to
perform a review on work-life research to determine the
number of articles that take sex/gender into account.
The second is to develop a model to summarize
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characteristics that can differentiate sex and gender
blind research, sex and gender differences research, and
gender research. The goal is to encourage researchers to
become aware of shortcomings in traditional gender-
blind research and the developmental potentials in gen-
der research.
The model is referred to as a “Tool”; however, it is
more accurate to refer to it as a table that defines char-
acteristics of research studies that are sex/gender blind
versus sex/gender differences versus gender research.
The limitation of this model is that the complexities of
the connections between sex and gender are not fully
taken into account. This resource can be used in assist-
ing researchers in defining their current research as sex/
gender blind versus gender research as well as encourage
the design of research that takes sex/gender into ac-
count. This paper can be used by investigators reviewing
the literature for studies on the impact of gender in hu-
man health, and it provides a model for distinguishing
among sex/gender blind research, sex/gender difference
research, and gender research.
Conclusions
It is critically important to consider both sex and gender
in research design, implementation, analysis, and inter-
pretation. Sex- and gender-based comparisons can pro-
vide clues into disease mechanisms that could lead to
new drug targets and treatment strategies, while analyz-
ing data by sex and gender will enhance scientific rigor
and reproducibility. Not considering sex and gender has
adverse consequences for human health, not only
through missed opportunities for therapeutic discovery
but because sex and gender can impact the frequency
and magnitude of adverse events. NIH has recognized
the importance of these issues and, soon, failure to take
sex into account will make applicants noncompliant
when applying for NIH funding. Notice NOT-OD-15-
102 released by NIH on June 9, 2015 requires that all
applications submitted to the NIH on January 25, 2016
and thereafter, “NIH expects that sex as a biological vari-
able will be factored into research designs, analyses, and
reporting in vertebrate animal and human studies.
Strong justification from the scientific literature, prelim-
inary data, or other relevant considerations must be pro-
vided for applications proposing to study only one sex”
[5]. Including sex as a biological variable into research
design can be a new and potentially complicated process
for both established researchers that now need to change
the way in which they have been conducting research
and for new researchers seeking guidance in developing
appropriate approaches.
This timely review provides a state-of-the-art anno-
tated bibliography of sex and gender analytic resources
to encourage and assist researchers in their efforts to
design studies that include sex and gender, and to col-
lect, analyze, and report sex and gender disaggregated
data. Additionally, the authors sought to perform a review
of each resource identified using previously established
qualities. To our knowledge, such a comprehensive review
has not previously been conducted.
Our review of the literature through 2014 yielded 69
resources. After excluding resources that did not meet
the eligibility criteria, 38 resources were identified and a
database of these resources was created. Of the seven
questions the review team set out to answer, we were
not able to answer two questions. For question 7: “What
is the level of evidence on which the resources are
based?” insufficient data was available to determine the
level of evidence for the identified resources. This lack
of data could potentially represent a lack of rigorous
study design for the resources and may indicate limita-
tions in their future impact and reproducibility. In
addition, this highlights the continued need to improve
available resource tools for researchers that meet rigor-
ous standards and measured outcomes. Additionally
question 4: “Who are the intended audience of these
resources?” was excluded as the “audience” could be
broadly interpreted and many of the audience categories
overlapped.
Taking both sex and gender into account in research are
necessary, although not sufficient, to create evidence-
based prevention, screening, diagnosis, and treatment
plans for individuals and populations. There are multiple
dimensions to sex and gender, which are important to
consider—such as race/ethnicity, class/caste, age but are
beyond the scope of this review.
Since the completion of this study, several resources
have become newly available to assist researchers. A key
resource is the NIH Office of Research on Women’s
Health “The Science of Sex and Gender in Human
Health,” an online educational source for courses offered
as continuing education at no cost. Future resource tools
such as this will be crucial to the successful integration
of the new NIH mandate. Additionally, the landmark
textbook that gathers important information in the field
of sex- and gender-based biology and clinical medicine,
“Principles of Gender-Specific Medicine: Gender in the
Genomic Era” by Legato will soon be available in its
third edition. Repositories for these resources will also
be imperative as knowledge and access to varied re-
sources is currently challenged by the lack of a central-
ized institute. The Sex and Gender Women’s Health
Collaborative (SGWHC) is an interdisciplinary group of
clinicians and researchers that through a collaborative
effort created a digital library of evidence-based sex and
gender resources to foster a sex and gender approach to
research, education, and health. The authors anticipate
that this review will also serve to broaden the outreach
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of SGWHC and similar organizations that serve to pro-
vide channels for sex- and gender-based health scientific
journal discovery.
Based on our review and analysis, we propose the fol-
lowing recommendations to assist and guide research
development and dissemination of the incorporation of
sex and gender in research.
1. Funding agencies should assign preference points to
grant proposals which include a sex and gender
component in the study design, data collection, data
analysis, interpretation, and reporting. An example
would be the mechanism used by Health Resource
and Services Administration grants for a variety of
statutory funding preferences.
2. Institutional Review Boards for ethical conduct of
human subject research and the FDA should make it
mandatory for researchers to take into account sex
and gender in the design and conduct of new
research studies.
3. Institutional Offices of Research Development
should assist investigators in developing their
research projects with a sex and gender lens.
4. Scientific journals should consider expanding
publication criteria for new manuscript
submissions—particularly for papers focused on
evidence-based medicine—to ensure that sex and
gender are addressed
Limitations of this review are the consideration that
resources are continuing to be developed and released
that may not have been included by the time of publica-
tion. This is a consequence of the rapidly emerging rec-
ognition of the incorporation of sex and gender in
research design. The review also did not include lan-
guages other than English.
This review of resources provides much needed infor-
mation to assist basic researchers, clinical investigators,
epidemiologists, population, and social scientists in con-
sidering the impact of sex and gender in their field of in-
vestigation and encourage the design of studies to
elucidate the cause and consequences of these funda-
mental variables. There is a growing appreciation in the
biomedical community of (1) the value of studying the
role of sex and gender in measures and outcomes and
(2) of how sex- and gender-based comparisons can in-
form research into disease mechanisms and the develop-
ment of new therapeutics. Analyzing data by sex and
gender will also improve the rigor and reproducibility of
science. We expect that this review will facilitate individ-
ual selection of helpful resources and tools to expand
toolboxes and widely assist a diverse audience of bio-
medical researchers to conduct research that ultimately
aims to improve health outcomes for men and women.
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